Description

12β-Acetyloxy-3β,7β-Dihydroxy-11,15,23-Trioxo-5α-Lanost-8-En-26-Oic Acid is a highly functionalized lanostane-type triterpenoid derivative, recognized for its complex molecular architecture and significant potential as a key synthetic intermediate. This compound matters for its role in advanced pharmaceutical research, particularly in the synthesis and structural modification of bioactive natural products. It is primarily needed by research institutions and pharmaceutical companies engaged in the development of novel therapeutic agents, including anti-inflammatory and anti-cancer candidates, as well as by fine chemical manufacturers specializing in complex organic synthesis.

Application

• Pharmaceutical Intermediate: Serves as a critical building block for the synthesis of novel steroid-like compounds and triterpenoid derivatives with potential therapeutic activity.
• Biochemical Research: Used as a reference standard or probe in metabolic pathway studies and enzyme inhibition assays due to its specific functional groups.
• Natural Product Synthesis: Acts as a key precursor in the semi-synthesis of complex natural products, enabling structure-activity relationship (SAR) studies.
• Medicinal Chemistry: Employed in drug discovery programs for the design and development of new chemical entities targeting various disease pathways.
• Fine Chemical Production: Utilized in the multi-step synthesis of high-value, specialized chemicals for research and development purposes.

Basic Information

Product Name	12β-Acetyloxy-3β,7β-Dihydroxy-11,15,23-Trioxo-5α-Lanost-8-En-26-Oic Acid
CAS No.	104700-95-0
Molecular Formula	C32H44O9
Molecular Weight	572.70 g/mol
Synonyms	12β-Acetoxy-3β,7β-dihydroxy-11,15,23-trioxo-5α-lanost-8-en-26-oic acid; 3β,7β-Dihydroxy-12β-acetoxy-11,15,23-trioxolanost-8-en-26-oic acid; Lanostane-26-oic acid, 12-(acetyloxy)-3,7-dihydroxy-11,15,23-trioxo-, (3β,5α,7β,12β)-; 12β-Acetyloxy-3β,7β-dihydroxy-11,15,23-trioxo-5α-lanost-8-en-26-oic acid; (3β,5α,7β,12β)-12-(Acetyloxy)-3,7-dihydroxy-11,15,23-trioxolanost-8-en-26-oic acid
EINECS	Contact for details

Quality Control

Our 12β-Acetyloxy-3β,7β-Dihydroxy-11,15,23-Trioxo-5α-Lanost-8-En-26-Oic Acid is produced under strict quality management protocols. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, IR, MS), to ensure it meets the high standards required for research and development. A comprehensive Certificate of Analysis (COA) detailing purity, assay, and impurity profiles is provided with every shipment to guarantee traceability and consistency.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) in a dry, well-ventilated area. This compound may be sensitive to moisture and prolonged exposure to elevated temperatures.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 95.0%
Assay	≥ 97.0%
Water Content (KF)	≤ 2.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.